RNA Quality Assessment Using Bayesian Algorithms

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for determining RNA sample quality are manual, subjective, and unreliable, especially in high-throughput analyses, as they rely on visual inspection and simple ratios of RNA fragments, which are inaccurate due to variations in RNA size distributions caused by contamination and mechanical shearing.

Innovation Solution

An automated method using electropherograms from the Agilent 2100 Bioanalyzer to extract significant features and apply a quality algorithm, based on Bayesian methods and neural networks, to objectively assess RNA sample integrity independently of source, preparation, and concentration, allowing for standardized quality control and assurance across different RNA samples.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If manual visual inspection methods are used for RNA quality determination, then experienced biochemists can subjectively assess sample integrity, but the process becomes unacceptable for high-throughput analyses due to time consumption and subjectivity

Engineering Contradiction:
Improvequality determination accuracyVSAvoidthroughput capability
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent replaces manual visual inspection with automated digital image analysis using software algorithms to objectively evaluate RNA quality from electrophoresis images. The system automatically detects and measures RNA bands, calculates integrity ratios, and generates quality assessments without human intervention, thereby eliminating subjectivity while enabling high-throughput processing of multiple samples simultaneously.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The system enables self-service quality assessment by automatically processing electrophoresis images through standardized algorithms that objectively determine RNA integrity. The software independently performs band detection, measurement, and quality calculation without requiring experienced biochemists, making the process both automated and reproducible for high-throughput applications.

Inventive Principle:
Principle #25Self-service

2Productivity

If simple ratio criteria (28S/18S) are used for automatic quality determination, then high-throughput analysis is enabled, but accuracy deteriorates due to large deviations from theoretical values in practice

Engineering Contradiction:
Improveautomated processing capabilityVSAvoidquality assessment accuracy
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The patent moves beyond the simple 28S/18S ratio by introducing multiple parameters for quality assessment, including intensity ratios, positional relationships, and morphological features of RNA bands. The system evaluates several characteristics simultaneously rather than relying on a single ratio, thereby improving accuracy while maintaining automated high-throughput processing capability.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The quality assessment system combines multiple evaluation criteria into a composite quality score. Instead of using a single ratio parameter, the system integrates information from band intensities, positions, shapes, and relative relationships to generate a comprehensive quality determination that is more accurate and robust against deviations from theoretical values.

Inventive Principle:
Principle #40Composite materials

3Measurement precision

If multiple features are extracted from electropherograms for quality assessment, then measurement accuracy improves, but device and algorithm complexity increases

Engineering Contradiction:
Improvequality determination reliabilityVSAvoidalgorithm complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent segments the electrophoresis image into distinct regions corresponding to different RNA bands (28S, 18S, and other fragments). By dividing the complex image analysis into separate band detection and measurement tasks, the system can extract multiple features from each segment independently and then integrate them for comprehensive quality assessment, managing complexity through structured segmentation.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system performs preliminary processing of electrophoresis images by automatically detecting and localizing RNA bands before extracting quality features. This preliminary action of identifying band positions and intensities first simplifies subsequent feature extraction and quality calculation steps, enabling accurate multi-parameter assessment without overwhelming algorithmic complexity.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach provides a reliable, objective, and reproducible quality assessment of RNA samples, reducing human error and enabling accurate comparisons and quality standards across various RNA samples, with high accuracy and robustness, as demonstrated by low disagreement with manual labeling.

Implementation Method 1

Lab-on-a-chip analyses using the Agilent 2100 Bioanalyzer, as provided by the applicant Agilent Technologies, provide an accurately reproducible, high-resolution, approach to gel-electrophoresis.

Methodology Applied
Scientific EffectCapillary electrophoresis: Capillary Electrophoresis

Data Source

PatentUS8346486B2Determining the quality of biomolecule samples
Publication Date: 2013.01.01 AGILENT TECHNOLOGIES INC
  • US8346486B2 patent drawing
  • US8346486B2 patent drawing
  • US8346486B2 patent drawing

AI summary

Disclosed is a method for determining the quality, expressed in terms of a quality value, of an biomolecule sample, based on measured data of the biomolecule sample, by extracting a number of prescribed features from the measured data using data analysis, and determining the quality value from the extracted features using a quality algorithm.